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Differential expression of type I collagen and cellular fibronectin
isoforms in endothelial cell variants. Endothelial cells in vivo and in vitro
are inherently capable of manifesting more than one phenotype. Most
endothelial cells in culture, even when maintained at confluent density
for an extended period, exhibit only the typical polygonal morphology.
Other cultures, albeit few, are characterized by rapid formation of
variant "sprout" cells once the cobblestone monolayer is established.
In vivo studies have revealed sprout cell formation to be one of the
early events in neovascularization. Therefore, elucidation of the factors
involved in this process is needed to gain an understanding of the
sprouting phenomena. To this end, two morphologically distinct bovine
endothelial cell clones derived from a fetal left ventricle were charac-
terized. One culture of cells stably displayed the conventional polygo-
nal phenotype, in contrast to the second culture in which an intercon-
necting network of sprout cells reproducibly developed beneath the
cobblestone monolayer. Analysis of extracellular matrix proteins and
RNA transcripts revealed that the sprouting clone showed induction of
type I collagen and a shift in fibronectin RNA processing resulting in
synthesis of the cellular isoforms. These collagenous and non-collage-
nous matrix molecules may serve in some manner to affect the
processes required during angiogenesis, that is, cell division, cell
migration and cell shape change.
Increasing importance is being attributed to the reciprocal
interactions which occur between endothelial cells and their
immediate environment [1, 2]. These events manifest them-
selves in a variety of forms. Some originate with cell-contact
resulting in formation of specialized types of cell junctions,
while others begin as receptor-mediated processes between cell
membrane-bound receptors and ligands [3, 4]. Specific interac-
tions can depend upon the existence of unique sequences or
structural domains within the extracellular matrix molecules or
can involve recognition of soluble or matrix-bound growth
factors [3, 5]. The subendothelial environment contains a di-
verse spectrum of matrix components and tissue cell types
whose presence dictates a large number of potentially important
and complex interactions. While information about the compo-
sition of the subendothelial matrix has increased, relatively
little is known about the biological significance of many of these
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domain B; ED-A, extra domain A; Ill-CS, Type III connecting seg-
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© 1993 by the International Society of Nephrology
matrix molecules and how they are related to endothelial cell
function.
Inherent in higher organisms is the ability to initiate forma-
tion of new blood vessels and to repair existing damaged ones.
These processes require that the endothelium be able to re-
spond mitotically to appropriate stimuli as well as undergo
specific cellular rearrangements. Normally, endothelium exists
as a quiescent, contact-inhibited monolayer with a relatively
low mitotic index [6—8]. However, in response to a variety of
stimulatory factors that occur during development, injury and
neovascularization, the endothelial cells migrate, divide and
display an altered pattern of protein production. Often associ-
ated with these events is a change in morphology from a
polygonal shape to an elongated form known as a "sprout".
The original in vivo description of sprouting was reported by
Ausprunk and Folkman [9], who speculated that the initial step
in the formation of new blood vessels in the rabbit cornea
required "budding" or "sprouting" of irregular-shaped, migra-
tory endothelial cells from the pre-existing vessel wall. Shortly
afterwards, comparable morphologic variants in cultured bo-
vine aorta endothelial cells were identified [8, 10, 11]. Based
upon morphology (stellate rather than polygonal) and position
(beneath the monolayer instead of contiguous with it), these
cells are considered phenotypically distinct from the vast ma-
jority of cells expressing the polygonal phenotype. Once
formed, the variants or "sprouts" interconnect to produce a
reticular network underneath the monolayer from which they
originated. Upon trypsinization and/or subculturing, the
"sprout" cell reverts to the polygonal phenotype but again
reappears after the culture achieves confluency. Sprout cells
are von Willebrand factor positive and, based upon this widely
accepted criterion, are considered bona fide endothelial cells.
Taken together, the data suggest that endothelial cells are
capable of switching between these two phenotypes when the
proper conditions prevail. The fact that sprout cells spontane-
ously arise strongly implies that the endothelial cells themselves
are capable of modifying their environment and that some cells
respond to these modifications by differentiating to the sprout-
ing phenotype. Still unanswered are the questions of what
factors govern the initial events leading to sprout cell formation
and what role these cells and their products play in the
neovascularization process.
To approach these issues, studies were initiated using mor-
phologically-distinct endothelial cell clones derived from a fetal
bovine left ventricle. The primary aim was to examine several
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Fig. 1. Morphologic dUferences in endothelial cell cultures. Panels A and B shows cells exhibiting the swirled and polygonal morphology,
respectively, which is characteristic of the majority of normal clones. Panels C and D show the appearance of sprouting cells seen in post-confluent
cultures only of morphologically variant clones, and panels E and F show later stages of the sprouting cultures where cells form networks and
tubular structures. Bar, 100 sm. Reproduced with permission from Academic Press [26].
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Time after subculture
3 Days 8 Days
medium supplemented with 16% FBS. The cell suspension was
diluted to five cells per ml and 200 microliters were pipetted into
each well of a 96 well plate.
Poly A RNA extraction and Northern blot hybridization
Poly A enriched RNA was isolated from 8 T175 cm2 flasks of
the cloned cells at three and eight days following subculture as
previously described [131. The endothelial cell RNA was passed
twice through the resin to enrich for poly A containing tran-
scripts. Poly A RNAs were electrophoresed for 22 hours at 30
V in a 1% agarose gel containing 2.2 NI formaldehyde [14].
Filter-bound RNAs were hybridized to 2 to 3 nglml of P-
labeled (1 to 1.5 X iO cpm/g) human DNA clones. Final wash




Fig. 2. Expression of types I and Ill collagen genes in the normal (N)
and sprouting (S) endothelial cell clones. Poly A RNAs (one microgram
per lane), isolated 3 and 8 days after subculture, were hybridized to
32P-labeled human cDNA inserts: al(I) Hf677; a2(I) 26 and al(III) E6.
The al(I) transcripts are 5.8 and 4.8 kb. Autoradiography time was 48
to 52 hours.
major extracellular matrix molecules which are intrinsic com-
ponents of the subendotheium and which are known to modify
endothelial cell behavior and adhesion. The results presented
here demonstrate that major differences in the types and
relative amounts of collagen and fibronectin exist between
cultures exhibiting the normal cobblestone and variant sprout
cell phenotype. This in vitro model system may prove valuable
for elucidating some of the early molecular events associated
with the angiogenic process.
Methods
Isolation of cloned fetal bovine endothelial cells
Endothelium was isolated from fetal bovine hearts by gentle
scraping of the intima with a scalpel blade and placed in fresh
Medium 199 (M199). Cells were centrifuged, resuspended in
Ml99 [12] with 16% fetal bovine serum (FBS) and incubated
overnight at 37°C in 5% CO2 in air. To insure that there were no
contaminating cell types, pure cell strains of endothelial cells
were cloned from primary cultures. Cells were trypsinized,
centrifuged, and resuspended in medium containing equal
amounts of modified M199 and smooth muscle cell conditioned
Collagen cDNA probes consisted of 1.3 to 2 kb inserts from
clones al[I} HF677, a2[I] 26 and csl[III] E6 [14 and refs.
therein]. The von Willebrand factor DNA was a 1.7 kb insert
from a full-length clone characterized by Lynch et a! [15].
A fibronectin genomic subclone containing 250 nucleotides of
the 273 nucleotide Extra Domain B (ED-B) exon was received
from Dr. Alberto Kornblihtt [16]. DNA subclones specific for
Extra Domain A (ED-A) and the Type III connecting segment
(111-CS) [reviewed in 17, 18], respectively, were obtained from
overlapping 2.0 and 2.6 kb clones that were isolated from a
human HT1O8O cDNA library (Myers and Pihlajaniemi, unpub-
lished results). The DNA sequence of the region covered by our
clones had been reported by Kornblihtt, Vibe-Pederson and
Baralle [19, 20] and Vibe-Petersen, Magnusson and Baralle [21].
A subclone specific for the 270 nucleotide ED-A exon was
constructed by ligating into the PstI site a 176 base pair
fragment. A subclone specific for the 360 nucleotide 111-CS
region was constructed by blunt end ligation into the BamHI
site of a 291 base pair BstEIl: AccI fragment. A 649 nucleotide
AvaI/HindIII fragment coding for most of the fibronectin RNA
3'untranslated region (3'UTR) served as the probe common to
all transcripts.
Slot blot hybridization of poly A RNA to fibronectin DNA
fragments
Slot blots of six concentrations of RNA, 0.031 to 0.5 g, were
made from 5 ng/pi stock solutions. Salmon sperm tRNA was
added to give a final concentration of 0.5 g per 200 tl aliquot.
RNA samples were heated for 15 minutes at 65°C in 7%
formaldehyde, 6x SSC and applied to 6x SSC equilibrated
nitrocellulose filters. Wells were washed twice with 200 sl 6x
SSC and the filters were baked and hybridized as above. Slots
were scanned with a densitometer, peak areas were cut out and
weighed and the values plotted against concentration of RNA.
In all instances, at least three of the six slots scanned fell within
a linear density range.
Immunoperoxidase and immunofluorescence microscopy
Cells, 10,000 cells per chamber, were plated onto LabTak 8
chamber slides and incubated at 37°C for various times to
permit sprouting and tube formation. Extracellular type I col-
lagen localization was achieved by immunohistochemistry us-
ing a 1:100 dilution of a human type I monoclonal antibody
provided by Dr. Nirmala SunderRaj (University of Pittsburgh,
Pittsburgh, Pennsylvania, USA). For immunofluorescence
al[lJ
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Fig. 3. Immunolocalization of type I collagen to cells with the sprout morphology. Normal (A) and sprouting (B) endothelial cell clones were
treated with antibody for type I collagen and localization was detected by a peroxidase reaction product. Only sprout cells in panel b stained





Fig. 4. Steady state levels of fibronectin and von Willebrand factor
(vWF) RNAs. RNAs isolated from normal (N) and sprouting (S)
cultures 8 days after subculture were hybridized to vWF cDNA and a 3'
UTR fibronectin probe (Methods). Autoradiography times were 16
hours for fibronectin and 48 hours for vWF. Fibronectin RNA is 8.8 kb
and vWF RNA is 9 kb.
staining of fibronectin, rhodamine-conjugated goat anti-mouse
or goat anti-rabbit IgG (Cappel Laboratories) was used as the
secondary antibody. The antibody for plasma fibronectin has
been previously characterized [22] and the monoclonal anti-
body to the ED-A region [23] was donated by Dr. Luciano
Zardi. Control cultures were incubated without a primary
antibody or in the presence of an unrelated monoclonal anti-
body. Cells were fixed and treated according to Wagner,
Olmstead and Marder [24], and any endogenous peroxidase
activity was quenched by incubation with 0.3% hydrogen
peroxide for 30 minutes. Cells were examined on a Zeiss
microscope and photographs were taken using Kodak Tri-X
film, ASA 1600, and processed in Diafine developer.
Results
Cloned bovine endothelial cells exhibit variant morphologic
phenotypes
Twenty endothelial cell clones were established and main-
tained through 30 population doublings, During this time,
cultures with two morphologically distinct groups of cells
emerged. Fifteen endothelial cell clones grew in an initial
swirled-like array (2 to 3 days after passage) and then rear-
ranged (5 to 8 days after passage) to form the normal cobble-
stone monolayer (Fig. 1 A and B) [25, 26]. In contrast, five
clones bypassed the swirled stage, briefly attained the polygo-
nal shape and then quickly formed a branching network of
sprout cells (Fig. 1 C and D). Upon extended time in culture,
the sprout cells interconnected and formed a tubular-like net-
work (Fig. 1 E and F).
One clone with the normal phenotype (designated N) and one
clone with the sprouting phenotype (designated S) were chosen
for detailed nucleic acid and biochemical analyses at three
and/or eight days after subculture. Only the cells in the swirled
array ("N", 3 days) showed a significant difference in cell
number, being twice that of the polygonal monolayer ("N", 8
days) or the sprouting cultures at either 3 ("S", 3 days) or 8
days ("S", 8 days) after passage. All cultures stained positive
for von Willebrand factor [27 and data not shown].
Expression of the al[I] collagen gene only in the sprout cell
variants
Analysis of the collagen RNAs synthesized by the endothelial
clones with the sprouting versus swirled/polygonal morphology
revealed a striking difference. For the first time in the bovine
endothelial cells that we have examined [14] there was expres-
sion, and at high levels, of the a! [I] collagen gene (Fig. 2). Only
in cultures containing the sprout cells were the two translational
prerequisites for type I collagen produced, since a2[I] RNA was
about equally represented in both N and S endothelial cell
clones. Type III collagen RNA showed a modest increase in the
sprouting cultures (Fig. 2) together with transcripts for the
a2(V) chain [25].
To determine if the change in type I collagen gene expression
could be specifically attributed to the morphologic variants, the
normal and sprouting clones were analyzed for extracellular
localization of type I collagen. As shown in Figure 3 [and 26],
examination of the clone with the normal polygonal phenotype
revealed that type I staining was essentially negative except for
a few isolated cells. In contrast, the immunoperoxidase reaction
product was readily apparent in the sprouting culture and
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for these cell types [7, 27]. To investigate the expression of
these genes in the endothelial cell clones, Northern blot hybrid-
ization was carried out using the specific cDNA probes. As
shown in Figure 4, the steady state levels of vWF RNA in the
two cultures appeared equal, whereas the abundance of fi-
bronectin transcripts was considerably elevated in the sprout
cell culture.
Preferential synthesis of cellular fibronectin by sprout cell
cultures
NS
Fig. 5. Northern blot hybridization offibronectin splice-specific DNA
probes. Fibronectin DNA fragments coding for the ED-B, ED-A and
Ill-CS splice domains and a fragment coding for the 3' UTR (Methods)
were hybridized to one microgram of poly A RNA per lane. Autora-
diography time for the 3' UTR filter was 16 hours and 48 to 52 hours for
the other three filters.
Little reactivity was found to be associated with the adjacent
polygonal cells.
Steady state levels of fibronectin and von Willebrand factor
RNAs
Endothelial cells also synthesize and secrete fibronectin and
von Willebrand factor into the matrix; both of which contain
binding sites for the interstitial collagens. Fibronectin has a
widespread distribution and interacts with cells via a specific
cell-binding domain to promote cell attachment and spreading
[17, 28, 291. von Willebrand factor is only produced by endo-
thelial cells and megakaryocytes and is thus a reliable marker
Northern blot hybridization using fibronectin probes revealed
several similarly sized transcripts. In the swirled/polygonal
endothelial cells, one major and one minor size class of RNA
were found, while in the sprouting cultures, additional species
were noted. These differences introduced the possibility of a
change in RNA splicing involving the regions: extra domain B
(ED-B), extra domain A (ED-A) and type III repeat connecting
segment (Ill-CS) [16—18]. The first two exons are found in
transcripts encoding the cellular but not plasma form of the
protein. At the 111-CS region, several splice combinations exist
resulting in size differences between the subunits constituting
the fibronectin dimer.
To distinguish among changes in the representation of the
fibronectin isoforms, cDNA probes specific for the three splice
domains and a common probe coding for the 3'UTR region
were employed [19]. Results of the Northern blot hybridizations
(Fig. 5) demonstrated that the normal, but not the sprouting,
endothelial cell clone synthesized very low amounts of RNAs
containing the ED-B and ED-A regions, while the increase in
Ill-CS containing transcripts in the sprouting cultures appeared
to parallel those detected using the common 3'UTR probe.
To confirm these observations, slot blots of six RNA concen-
trations were first hybridized to the ED-B and ED-A probes,
respectively, and afterwards to the Ill-CS and 3'UTR probes
(Fig. 6). Densitometric scans established that the sprouting
culture produced 5.5 and 6.2 times more ED-B and ED-A
containing transcripts, respectively, than did the normal culture
compared with values of 2.0 and 2.4 which were obtained using
the Ill-CS and 3'UTR probes.
To ensure that the alteration in fibronectin RNA processing
was specific for the variant endothelial cells, cultures containing
aggregates of sprout cells and tubes were stained with an
antibody specific for the ED-A domain provided by Dr. Luciano
Zardi. In contrast to the ubiquitous staining readily apparent
when using an antibody for plasma fibronectin (Fig. 7A) [26],
the ED-A probe identified only areas of sprout cells and
capillary-like structures (Fig. 7C and D) [26].
Discussion
These studies provide information on extracellular matrix
gene expression in cloned endothelial cells displaying the sprout
cell phenotype. They also augment earlier investigation of the
differences in collagen RNAs synthesized by bovine and human
polygonal endothelial cells versus smooth muscle cells and
fibroblasts [14]. Morphologically normal bovine endothelial
cells obtained from vena cava, aorta, pulmonary artery [14] and
left ventricle all exhibit a similar pattern of collagen gene
expression: the presence of a2[l], al[III] and a2[V] transcripts
and absence of a! [I]. Perhaps, an initial set of events such as
— a — a — — a a
— a a - — — —a - -   a
I
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Fig. 6. Slot blot hybridization of endothelial cell RNAs tofibronectin probes. Six concentrations of poly A RNA (0.5 to 0.031 sg) on each of two
filters were hybridized first to ED-B and ED-A probes and then to 111-CS and 3' UTR DNAs, respectively (Methods). Autoradiography time was
17 hours for ED-A and 8 to 10 hours for the remaining filters.
change in chromatin structure or synthesis of transcription
factors [30] had occurred resulting in transcription of the a2[I]
gene (but probably not translation of the RNA). The cells are,
however, unable to produce type I collagen until a second signal
needed for activation or derepression of the al[I] gene takes
place. This latter switch seems directly related with the change
in cell morphology from the polygonal shape to the elongated
sprout.
Also associated with the change in cell morphology is the
alteration in fibronectin RNA processing. Whereas morpholog-
ically-normal bovine endothelial cells, synthesize almost en-
tirely plasma (ED-B, ED-A—) fibronectin RNA isoforms, cells
in the sprout morphology synthesize transcripts encoding the
cellular form of the protein. These differences can well be
interpreted within the context of the initial observations made
by McAuslan et al [31], before there was any knowledge of the
distinct fibronectin isoforms generated from alternative splic-
ing. These authors found an altered distribution of fibronectin in
cultures of morphologically variant (presumably sprouting)
bovine aorta endothelial cells. Unlike polygonal endothelial
cells which deposited matrix proteins underneath the mono-
layer, sprouts lost cellular polarity and displayed a vast increase
in fibronectin on their apical surface. This fibronectin formed a
trail behind the migrating sprouts that normal endothelial cells
seemed to follow. Therefore, the role proposed for the variants
was as "lead cells" or "pathfinders" which established a
fibronectin matrix required for the formation of new endothe-
hum. The data presented here supports the hypothesis that
cellular (ED-Bk, ED-Al is a necessary constituent of this
matrix.
Reports in the literature show that the presence of the ED-A
sequence in the fibronectin is correlated with developmental
changes [32], wound healing [33], and acute tissue and endo-
thehial cell injury [34, 35]. Moreover, there is enhanced repre-
sentation of ED-A in fetal and tumor tissue [36—38], trans-
formed cells [23, 36], fibroblasts treated with TGF-fl [39], and in
smooth muscle cells modulated in vivo by physiological stimuli
and in vivo by the formation of atherosclerotic lesions [40]. The
expression of ED-B, like ED-A, is closely associated with
developmental changes [32], wound healing [33], tumor tissue
[36], and migration and proliferation of embryonic cells [41].
Results from a number of laboratories imply that fibronectin
deposition in the extracellular matrix occurs prior to its asso-
ciation with collagen. McDonald [42] speculates that fibronectin
is required for normal collagen association and may serve as a
provisional scaffold for types I and III collagen. In particular,
the presence of type I collagen can also increase the complexity
of the matrix via the formation of type I/type III and type I/type
V heterotypic fibrils [43, 44]. Although the role of fibrillar
collagens in the endothelial cell matrix is not well understood,
their presence and accumulation would strengthen the original
architecture composed of more labile proteins such as fibronec-
tin. The fibronectin molecules produced by the sprout cells
would, in fact, seem to be especially unstable due to increased
susceptibility to proteolytic cleavage caused by inclusion of the
splice domains [23, 36].
A diverse group of glycoproteins (and degradative products)
constitutes the endothelial cell matrix [45] making it highly
probable that specific domains serve as cues or ligand specific
initiators of cell behavior which are instrumental during growth,
migration and differentiation. Continued analysis of the types,
quantities and spatial association of these components are
required to clarify the molecular mechanisms associated with
angiogenesis and vascular repair.
Acknowledgments
These studies were supported by NIH grants AR20553 and HL41882
and were performed in part with members of the Connective Tissue
Research Institute, E.J. Macarak, S.F. Gorfien and P.S. Howard.
Figures 1 and 7 were reproduced as originally reported (Dev Biol
146:325—338) with the permission of Academic Press. These data were
presented at the FASEB Summer Research Conference (August 1991)
"Modulation of Wound Healing and at the "Cell and Molecular Biology
of Basement Membranes in Health and Disease" (September 1991).
Reprint requests to Jeanne C. Myers, Ph.D., Department of Bio-
chemistry and Biophysics, University of Pennsylvania School of Med-




Myers: Matrix gene expression in sprouting endothelium 51
Fig. 7. Immunofluorescence of plasma and ED-A specific fibronectin antibodies to endothelial cell cultures. Staining representative of: (a) normal
and sprouting cultures using a plasma fibronectin antibody; (b) control cultures using a nonspecific secondary antibody; (c) a cluster of sprouting
cells using the ED-A monoclonal antibody, IST-9 [23]; and (d) tubular structures using the ED-A antibody. Bar, 10 m. Reproduced with
permission from Academic Press [26].
References
1. M.r,ai JA, WILLIAMS SK: Capillary endothelial cell cultures:
Phenotypic modulation by matrix components. J Cell Biol 97:153—
165, 1983
2. GIMBR0NE MA: Vascular endothelium: Nature's blood container,
in Vascular Endothelium in Hemostasis and Thrombosis (Chapt.
1), edited by GIMBRONE MA JR. Edinburgh, Churchill Livingstone,
1986, pp. 1—13
3. HUMPHRIES MJ, OBARA M, OLDEN K, YAMADA KM: Role of
fibronectin in adhesion, migration, and metasis. Cancer Invest
7:379—393, 1989
52 Myers: Matrix gene expression in sprouting endothelium
4. INGEAR DE: Fibronectin controls capillary endothelial cell growth
by modulating cell shape. Proc NatI Acad Sci USA 87:3579—3583,
1990
5. RYAN US: Receptors on pulmonary endothelial cells. Am Rev
RespirDis 141:Sl32—Sl36, 1990
6. GIMBRONE MA, COTRAN RS, FOLKMAN J: Human vascular endo-
thelial cells in culture: Growth and DNA synthesis, J Cell Biol
60:673—679, 1974
7. JAFFE EA, NACHMAN RL, BECKER CG, MINICK CR: Culture of
human endothelial cells derived from umbilical cord veins. J C/in
invest 52:2745—2752, 1973
8. SCHWARTZ SM: Selection and characterization on bovine aorta
endothelial cells. In Vitro 14:966—980, 1978
9. AUSPRUNK DH, FOLKMAN J: Migration and proliferation of endo-
thelial cells in preformed and newly formed blood vessels during
tumor angiogenesis. Microvasc Res 14:53—65, 1977
10. MCAUSLAN BR, REILLY W: A variant vascular endothelial cell line
with altered growth characteristics. J Cell Physiol 101:419—420,
1979
11. COTTA-PEREIRA G, SAGE H, BORNSTEIN P, Ross R, SCHWARTZ S:
Studies of morphologically atypical ("sprouting") cultures of bo-
vine aorta endothelial cells. J Cell Physiol 102:183—191, 1980
12. LEWIs U, HOAK JC, MACA RD, FRY GL: Replication of human
endothelial cells in culture. Science 181:454—455, 1973
13. PIHLAJANIEMI T, MYERS IC: Characterization of a pro a2(I)
collagen gene mutation by nuclease Si mapping. Meth Enzymol
145:213—222, 1987
14. MYERS JC, HOWARD PS, JELEN AM, DI0N AS, MACARAK EJ:
Duplication of type IV COOH-terminal repeats and species-specific
expression of aI(IV) and a2(IV) collagen genes. J Biol Chem
262:9231—9238, 1987
15. LYNCH DC, ZIMMERMAN TS, COLLINSCJ, BROWN M, MORIN MJ,
LING EH, LIVINGSTON DM: Molecularcloning of cDNA for human
von Willebrand factor: Authentication by a new method. Cell
41:49—56, 1985
16. GUTMAN A, KORNBLIHTT AR: Identification of a third region of
cell-specific alternative splicing in human fibronectin mRNA. Proc
Nail Acad Sci USA 84:7179—7182, 1987
17. HYNES RO: Molecular biology of fibronectin. Ann Rev Cell Biol
1:67—90, 1985
18. KORNBLIHTT AR, GUTMAN A: Molecular biology of the extracel-
lular matrix proteins. Biol Rev 63:465—507, 1988
19. KORNBLIHTT AR, VIBE-PEDERSEN K, BARALLE FE: Isolation and
characterization of eDNA clones for human and bovine fibronec-
tins. Proc Natl Acad Sci USA 80:3218—3222, 1983
20. KORNBLIHTF AR, VIBE-PEDERSEN K, BARALLE FE: Human fi-
bronectin: Cell specific alternative mRNA splicing generates
polypeptide chains differing in the number of internal repeats. Nuci
Acid Res 12:5853—5968, 1984
21. VIBE-PEDERSEN K, MAGNUSSON 5, BARALLE FE: Donor and
acceptor splice signals within an exon of the human fibronectin
gene: A new type of differential splicing. FEBS Lett 207:287—291,
1986
22. MACARAK EJ, HOWAIW PS: Adhesion of endothelial cells to
extracellular matrix proteins. J Cell Physiol 116:76—86, 1983
23. BORSI L, CARNEMOLLA B, CASTELLANI P, ROSELLINI C, VECCHIO
D, ALLEMANNI G, CFIANG SE, TAYLOR-PAPADIMITRIOU J, PANDE
H, ZARDI L: Monoclonal antibodies in the analysis of fibronectin
isoforms generated by alternative splicing of mRNA precursors in
normal and transformed cells. J Cell Biol 104:595—600, 1987
24. WAGNER DD, OLMSTEAD JB, MARDER VJ: Immunolocalization of
von Willebrand protein in Weibel-Palade bodies of human endothe-
hal cells. J Cell Biol 95:355—360, 1982
25. MYERS JC, HOWARD PS, WALTHER SE, GORFIEN SF, MACARAK
U: Collagen and fibronectin gene expression in cultured endothe-
hal cells. Ann NYAcad Sd 560:120—131, 1990
26. HOWARD PS, MYERS JC, GORFIEN SF, MACARAK EJ: Progressive
modulation of endothelial phenotype during in vitro blood vessel
formation. Dev Biol 146:325—338, 1991
27. JAFFE EA, HOYER LW, NACHMAN RL: Synthesis of antihemo-
philic factor antigen by cultured human endothelial cells. J C/in
invest 52:2757—2764, 1973
28. YAMADA KM: Cell surface interactions with extracellular materi-
als. Ann Rev Biochem 52:761—799, 1983
29. RUOSLAHTI E, PIERSCHHBACHER MD: Arg-Gly-Asp: A versatile
cell recognition signal. Cell 44:517—518, 1986
30. VUORIO E, DECROMBRUGGHE B: The family of collagen genes. Ann
Rev Biochem 59:837—872, 1990
31. MCAUSLAN BR, HANNAN GN, REILLY W, STEWARTFHC: Variant
endothelial cells. Fibronectin as a transducer of signals for migra-
tion and neovascularization. J Cell Physiol 104:177—186, 1980
32. FFRENCH-CONSTANT C, HYNES RO: Alternative splicing of fi-
bronectin is temporally and spatially regulated in the chicken
embryo. Development 106:375—388, 1989
33. FFRENCH-CONSTANT C, VAN DE WATER L, DVORAK HF, HYNES
RO: Reappearance of an embryonic pattern of fibronectin splicing
during wound healing in the adult rat. Development 109:903—914,
1989
34. LOCKWOOD CJ, PETERS JH: Increased plasma levels of EDI +
cellular fibronectin precede the clinical signs of preeclampsia. Am J
Obstet Gynecol 162:358—362, 1990
35. PETERS JH, GINSBERG MH, CASE CM, COCHRANE CG: Release of
soluble fibronectin containing an extra type III domain (ED1)
during acute pulmonary injury mediated by oxidants or leukocytes
in vivo. Am Rev Respir Dis 138:167—174, 1988
36. CARNEMOLLA B, BALZA E, SIRI A, ZARDI L, NIC0TRA MR,
BIGOTTI A, NATAL! PG: A tumor-associated isoform generated by
alternative splicing of messenger RNA precursors. J Cell Biol
108:1139—1148, 1989
37. OYAMA F, HIROHASHI S, CHIMOSATO Y, TITAN! K, SEKIGUCHI K:
Deregulation of alternative splicing of fibronectin pre-mRNA in
malignant human liver tumors. Biol Chem 264:10331—10334, 1989
38. VARTIO T, LAITINEN U, NARVANEN 0, CUTOLO M, THORNELL
LU, ZARDI L, VIRTANEN I: Differential expression of the ED
sequence-containing form of cellular fibronectin in embryonic and
adult human tissues. J Cell Sci 88:419—430, 1987
39. BALZA B, B0RSI L, ALLEMANNI G, ZARDI U: Transforming growth
factor B regulates the levels of different fibronectin isoforms in
normal human cultured fibroblasts. FEBS Lett 228:42—44, 1988
40. GLUKHOVA MA, FRID MG, SHEKHONIN BV, VASILEVSKAYA TD,
GRUNWALD J, SAGINATI M, KOTELIANSKY VE: Expression of
extra domain A fibronectin sequence in vascular smooth muscle
cells is phenotype dependent. J Cell Biol 109:357—366, 1989
41. FFRENCH-CONSTANT C, HYNE5 RO: Patterns of fibronectin gene
expression and splicing during cell migration in chicken embryos.
Development 104:369—382, 1988
42. MCDONALD JA: Extracellular matrix assembly. Ann Rev Cell Biol
4:183—207, 1988
43. BIRK DE, FITCH JM, BABIARZ JP, LINSENMAYER TF: Collagen
type I and type V are present in the same fibril in the avian corneal
stroma. JCell Biol 106:999—1008, 1988
44. KEENE DR, SAKAI UY, BACHINGER HP, BURGESONRE: Type III
collagen can be present on banded collagen fibrils regardless of
fibril diameter. J Cell Biol 105:2393—2402, 1987
45. MADRI JA, PRATT BM: Endothelial cell-matrix interactions: in
vitro models of angiogenesis. J Histochem Cytochem 34:85—91,
1986
